NCT06331572View on ClinicalTrials.gov

Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression

CompletedOBSERVATIONAL

Enrollment

162

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

October 25, 2021

Study Completion Date

December 20, 2023

Conditions

Psychiatric DisorderMajor Depressive DisorderMetabolic Disorder

Interventions

DIAGNOSTIC_TEST

17-HAMD

Patients were interviewed in a semi-structured manner and assessed using the 17-item Hamilton Depression Scale and the Hamilton Anxiety Scale

Trial Locations (1)

400000

The First Affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors

lead

First Affiliated Hospital of Chongqing Medical University

OTHER

NCT06331572 - Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression | Biotech Hunter | Biotech Hunter